Rare Stock Picks In June 2025 - From Discerning Analysts

These aren’t typical “hot” stocks but are instead lesser-known picks with strong fundamentals, niche positioning, or turnaround potential:

Rare Stock Picks – June 2025 Edition

1. Axcelis Technologies (ACLS)

• Sector: Semiconductors

• Why Analysts Like It: Strong exposure to ion implantation tools used in silicon carbide (SiC) production. Demand for power-efficient chips in EVs and industrials is surging.

• Valuation: PEG < 1, P/E below peers.

• Risk: Cyclical; tied to semiconductor capital spending.

2. Arcos Dorados Holdings (ARCO)

• Sector: Consumer Discretionary (McDonald's LATAM franchisee)

• Why Analysts Like It: Massive exposure to Latin America's recovering middle class. Margins improving post-COVID and inflation cycle.

• Valuation: EV/EBITDA attractive vs global peers.

• Risk: FX and political risk (especially Argentina and Brazil).

3. Enfusion, Inc. (ENFN)

• Sector: Fintech / SaaS

• Why Analysts Like It: A rare pure-play SaaS for asset managers and hedge funds. Sticky client base. Analysts note strong retention and ARR growth.

• Valuation: Low float, moderate market cap (~$1B), high revenue CAGR.

• Risk: Execution risk in global expansion.

4. ACI Worldwide (ACIW)

• Sector: Payment Infrastructure / Software

• Why Analysts Like It: Benefiting from banks upgrading real-time payment systems. Solid FCF and potential M&A target.

• Valuation: Discounted to peers like FISV or GPN.

• Risk: Competitive space; slower growth than newer fintechs.

5. Veritone, Inc. (VERI)

• Sector: AI / Media / Legaltech

• Why Analysts Like It: Niche AI applications in audio, law enforcement, and energy. Improved margins in 2025 after cost restructuring.

• Valuation: High volatility but attractive if revenue stabilizes.

• Risk: Highly speculative; negative earnings.

6. Tandem Diabetes Care (TNDM)

• Sector: Medtech

• Why Analysts Like It: High-growth diabetes device company with new tech pipeline. May be nearing inflection point after multi-quarter underperformance.

• Valuation: Beaten-down with upside from innovation cycle.

• Risk: Competitive threats (e.g., Insulet, Dexcom).

7. Cameco Corp (CCJ)

• Sector: Uranium / Energy

• Why Analysts Like It: Nuclear energy demand rebound. Uranium spot prices rising; CCJ has long-term contracts and pricing power.

• Valuation: Priced for growth, but supported by macro theme.

• Risk: Regulatory hurdles; supply volatility.

8. Mitek Systems (MITK)

• Sector: Identity Verification / AI

• Why Analysts Like It: Quiet leader in mobile check deposit and ID verification. AI-enabled fraud detection a key 2025 theme.

• Valuation: Undervalued after legal overhangs lifted.

• Risk: Customer concentration; tech disruption.